Tay-Sachs Disease Treatment Market is driven by Gene Therapy Advances
The Tay-Sachs Disease Treatment Market focuses on innovative therapeutics designed to slow or reverse neurodegeneration caused by HEXA gene mutations. Leading product categories include enzyme replacement therapies, gene editing approaches, and viral vector–based treatments that deliver functional genes to neuronal cells. These solutions offer advantages such as targeted delivery,...
0 Comentários 0 Compartilhamentos 123 Visualizações 0 Anterior